Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

類似資料

• Paradoxically Elevated Efavirenz Concentrations in HIV/TB Co-infected Patients with CYP2B6 516TT Genotype on Rifampin-containing Antituberculous Therapy
  著者:: Kwara, Awewura, 等
  出版事項: (2011)
• Slow Efavirenz Metabolism Genotype Is Common in Botswana
  著者:: Gross, Robert, 等
  出版事項: (2008)
• CYP2B6, CYP2A6 and UGT2B7 Genetic Polymorphisms are Predictors of Efavirenz Mid-dose Concentration in HIV-infected Patients
  著者:: Kwara, Awewura, 等
  出版事項: (2009)
• CYP2B6 (c.516G→T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
  著者:: Kwara, Awewura, 等
  出版事項: (2009)
• Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6
  著者:: Court, Michael H., 等
  出版事項: (2014)